AJMB-Avicenna Journal of Medical Biotechnology. 2017; 9 (1): 8-12
in English
| IMEMR
| ID: emr-185806
ABSTRACT
Background:
M2000 is a newly designed and safe Non-Steroidal Anti-Inflammatory Drug [NSAID]. The aim of this study was to assess the effects of M2000 on expression levels of Suppressor of Cytokine Signaling-1 [SOCS-1] and Src Homology-2 domain containing inositol-5'-phosphatase 1 [SHIP1] proteins via Toll-Like Receptor [TLR] 2/microRNA-155 pathway
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Src Homology Domains
/
MicroRNAs
/
Toll-Like Receptor 2
/
Suppressor of Cytokine Signaling 1 Protein
/
Iran
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Avicenna J. Med. Biotechnol.
Year:
2017
Similar
MEDLINE
...
LILACS
LIS